Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 28;18(10):e1010906.
doi: 10.1371/journal.ppat.1010906. eCollection 2022 Oct.

A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication

Affiliations

A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication

Seyedehmahsa Moghimi et al. PLoS Pathog. .

Abstract

As ultimate parasites, viruses depend on host factors for every step of their life cycle. On the other hand, cells evolved multiple mechanisms of detecting and interfering with viral replication. Yet, our understanding of the complex ensembles of pro- and anti-viral factors is very limited in virtually every virus-cell system. Here we investigated the proteins recruited to the replication organelles of poliovirus, a representative of the genus Enterovirus of the Picornaviridae family. We took advantage of a strict dependence of enterovirus replication on a host protein GBF1, and established a stable cell line expressing a truncated GBF1 fused to APEX2 peroxidase that effectively supported viral replication upon inhibition of the endogenous GBF1. This construct biotinylated multiple host and viral proteins on the replication organelles. Among the viral proteins, the polyprotein cleavage intermediates were overrepresented, suggesting that the GBF1 environment is linked to viral polyprotein processing. The proteomics characterization of biotinylated host proteins identified multiple proteins previously associated with enterovirus replication, as well as more than 200 new factors recruited to the replication organelles. RNA metabolism proteins, many of which normally localize in the nucleus, constituted the largest group, underscoring the massive release of nuclear factors into the cytoplasm of infected cells and their involvement in viral replication. Functional analysis of several newly identified proteins revealed both pro- and anti-viral factors, including a novel component of infection-induced stress granules. Depletion of these proteins similarly affected the replication of diverse enteroviruses indicating broad conservation of the replication mechanisms. Thus, our data significantly expand the knowledge of the composition of enterovirus replication organelles, provide new insights into viral replication, and offer a novel resource for identifying targets for anti-viral interventions.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Characterization of the APEX2-GARG-1060 proximity biotinylation system.
A. Domain organization of GBF1 and the C-terminally truncated GBF1 constructs fused to EGFP (positive control) and APEX2. Both GBF1 truncated constructs contain the BFA-resistant Sec7 domain from ARNO. B. Polio replicon replication was assessed in the presence or absence of 2μg/ml of BFA in HeLa cells transfected with plasmids expressing the C-terminally truncated GBF1 fusions with APEX2 or EGFP, or an empty vector C. Polio replicon replication assay was performed in control HeLa cells, or HeLa cells stably expressing APEX2-GARG-1060 with or without 2μg/ml of BFA. D. HeLa cells stably expressing APEX2-GARG-1060 were infected (or mock-infected) with 10 PFU/cell of poliovirus, and the biotinylation reaction was performed at 4 h p.i. The cells were processed for visualization of biotinylated proteins with a fluorescent streptavidin conjugate and immunostaining for a poliovirus antigen 3A. E. HeLa cells stably expressing APEX2-GARG-1060 were infected (or mock-infected) with poliovirus and the biotinylation reaction was performed as in D. The cells were stained with a fluorescent streptavidin conjugate and antibodies against a poliovirus antigen 2B and processed for structural illumination superresolution (SIM) microscopy. The arrow shows biotinylation-positive structures identified as stress granules. The scale bar is 10μm. F. HeLa cells stably expressing APEX2-GARG-1060 were infected (PV), or mock-infected (M) with 10 PFU/cell of poliovirus, and protein biotinylation was assessed after performing the biotinylation reaction at 4 h p.i. with biotin-phenol (BP) and hydrogen peroxide (complete reaction), or without one, or both compounds.
Fig 2
Fig 2. Known cellular proteins recruited to replication organelles are biotinylated by FLAG-APEX2-GARG1060.
A. HeLa cells stably expressing FLAG-APEX2-GARG-1060 were infected (PV), or mock-infected (M) with 10 PFU/cell of poliovirus, and biotinylation was performed at the indicated times post-infection. Biotinylated proteins were collected on streptavidin beads, resolved on SDS-PAGE and analyzed in a Western blot with HRP-conjugated streptavidin. B. Scheme of the biotinylation experiment to compare the biotinylated proteins (strep pull-down) with the proteins in the lysates before fractionation (input). The figure was made using Biorender templates. C. HeLa cells stably expressing APEX2-GARG-1060 were infected (PV), or mock-infected (M) with 10 PFU/cell of poliovirus, the biotinylation reactions were performed at 2, 4, and 6 h p.i., and the unfractionated cellular lysates (input) and the isolated biotinylated proteins (strep pull-down) were analyzed in a western blot with the indicated antibodies. Anti-FLAG antibodies detect the APEX2-GARG-1060 protein.
Fig 3
Fig 3. Biotinylation of viral proteins by APEX2-GARG-1060.
A. Poliovirus genome and polyprotein processing scheme. The cleavage sites for the viral proteases 2A, 3C, and 3CD are indicated by green, red, and blue-filled triangles, respectively. The dashed empty green triangle indicates a 2A cleavage site in 3D believed to be dispensable for replication. The purple star indicates the autocatalytic cleavage site in VP0. B. HeLa cells stably expressing APEX2-GARG-1060 were infected (PV), or mock-infected (M) with 10 PFU/cell of poliovirus, and biotinylation reactions were performed at the indicated times post-infection. Unfractionated cellular lysates (input) and isolated biotinylated proteins were analyzed in a Western blot with indicated antibodies. The antibodies recognize the final and intermediate polyprotein cleavage products containing the corresponding antigen. Red stars on anti-3A and anti-3D panels indicate polyprotein fragments that do not match the known polyprotein cleavage products.
Fig 4
Fig 4. Characterization of the proteome biotinylated by FLAG-APEX2-GARG1060.
A. In five independent experiments, HeLa cells stably expressing APEX2-GARG-1060 were infected (PV), or mock-infected (M) with 10 PFU/cell of poliovirus, and biotinylation was performed at 6 h p.i. Biotinylated proteins were purified on streptavidin beads and analyzed in a Western blot with HRP-streptavidin. Biotinylated proteins from these five experiments were pooled for proteomics analysis. Full proteomics data are available in S1 Data. B. Gene ontology (GO) enrichment analysis of the proteomics data using PANTHER classification system [69]. Buble graphs show the number of proteins associated with a particular GO term (bubble size), the log2 of enrichment over the expected non-specific associations of genes in the dataset with a particular GO term (x-axis), and the statistical significance of the observed enrichment (negative log10 of p-value, y-axis). Five of the most statistically significantly enriched GO terms for proteins from infected and mock-infected samples are shown. The full GO analysis is available in S2 Data. C. The distribution of the poliovirus-specific peptides identified by mass-spectrometry analysis across the poliovirus polyprotein. The x-axis shows amino-acid positions in the poliovirus polyprotein, the y-axis shows how many times a particular amino-acid was detected.
Fig 5
Fig 5. Effects of siRNA-mediated knockdown of expression of AldoA, EWSR1 and ILF3-90 on enterovirus replication.
A, B. HeLa cells were transfected with siRNAs specific to AldoA, EWSR1 and 90KDa isoform of ILF3, or non-targeting control siRNA, and polio or Coxsakie B3 replicon replication assays were performed 72 h post siRNA transfection. The total replication signal was calculated as the area under the corresponding kinetics curves. Cell viability signal is proportional to the level of ATP in cells. Western blots show the efficacy of siRNA-mediated knockdown of the targeted proteins. C. HeLa cells were transfected with siRNAs specific to AldoA, EWSR1 and 90KDa isoform of ILF3, or non-targeting control siRNA. 72 h post siRNA transfection cells were infected with an MOI of 1 PFU/cell of poliovirus or Coxsackie virus B3, and the total virus yield was determined at 6 h p. i. Western blots show the efficacy of siRNA-mediated knockdown of the targeted proteins. D. HeLa cells were transfected with siRNAs specific to 90KDa isoform of ILF3 or EWSR1 or a non-targeting control siRNA. 72h post siRNA transfection, the cells were transfected with a replication-defective replicon RNA containing the Δ3D mutation. The total translation signal was calculated as the area ander the curve from 1 to 4 h post Δ3D RNA transfection. Western blots show the efficacy of siRNA-mediated knockdown of the targeted proteins. E. HeLa cells were transfected with siRNAs specific to AldoA, EWSR1 and 90KDa isoform of ILF3, or non-targeting control siRNA, and cell viability assays detecting the level of ATP or the activity of the mitochondrial respiratory chain enzymes were performed 72h post siRNA transfection. Western blots show the efficacy of siRNA-mediated knockdown of the targeted proteins.
Fig 6
Fig 6. AldoA localization in infected and mock-infected cells.
A, B. Confocal images of HeLa cells infected (or mock-infected) with 10 PFU/cell of poliovirus, fixed at 4 h p.i. and stained with antibodies against AldoA and a viral antigen 2B (A), or AldoA and dsRNA (B). Scale bar is 10 μm.
Fig 7
Fig 7. Cytoplasmic translocation of EWSR1 and its association with stress granules upon poliovirus infection.
A. Confocal images of HeLa cells infected (or mock-infected) with 10 PFU/cell of poliovirus, fixed at 2, 4 and 6 h p.i and stained with antibodies against EWSR1 and the viral replication antigen 3B. B. High magnification confocal images of HeLa cells infected (or mock-infected) and processed as in A at 4 h p.i. Note the association of cytoplasmic EWSR1 signal outside of stress granules with the 3B-positive structures. C. Confocal images of HeLa cells infected (or mock-infected) as in A, fixed at 4 h.i. and stained with antibodies against EWSR1 and the stress granule component G3BP1. Scale bar is 10 μm. D. Confocal images of HeLa cells stably expressing APEX2-GARG-1060 infected (or mock-infected) as in A. C, and processed at 4 h p.i. to visualize biotinylated proteins and stained with antibodies to the stress granule component G3BP1. Scale bar is 5 μm.
Fig 8
Fig 8. ILF3-90 associates with dsRNA in poliovirus-infected cells.
A, B. Confocal images of HeLa cells infected (or mock-infected) with 10 PFU/cell of poliovirus, fixed at 4 h p.i. and stained with antibodies against ILF3-90 and the viral antigen 2B (A), or ILF3-90 and dsRNA (B). Scale bar is 10 μm. Note the concentration of ILF3-90 signal on the outer border of the replication organelles and its association with dsRNA inside the replication organelles.

Similar articles

Cited by

References

    1. Minor P. The polio endgame. Hum Vaccin Immunother. 2014;10(7):2106–8. doi: 10.4161/21645515.2014.981115 ; PubMed Central PMCID: PMC4370356. - DOI - PMC - PubMed
    1. Reed Z, Cardosa MJ. Status of research and development of vaccines for enterovirus 71. Vaccine. 2016;34(26):2967–70. doi: 10.1016/j.vaccine.2016.02.077 . - DOI - PubMed
    1. Oberste MS, Moore D, Anderson B, Pallansch MA, Pevear DC, Collett MS. In vitro antiviral activity of V-073 against polioviruses. Antimicrob Agents Chemother. 2009;53(10):4501–3. Epub 2009/07/29. AAC.00671-09 [pii]. doi: 10.1128/AAC.00671-09 ; PubMed Central PMCID: PMC2764203. - DOI - PMC - PubMed
    1. Thibaut HJ, De Palma AM, Neyts J. Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol. 2012;83(2):185–92. Epub 2011/09/06. doi: 10.1016/j.bcp.2011.08.016 S0006-2952(11)00667-8 [pii]. . - DOI - PubMed
    1. Benschop KSM, Van der Avoort HGAM, Duizer E, Koopmans MPG. Antivirals against enteroviruses: a critical review from a public-health perspective. Antivir Ther. 2015;20(2):121–30. doi: 10.3851/IMP2939 WOS:000359909200002. - DOI - PubMed

Publication types